Furthermore, strong associations of hypermethylation in GATA4 and VIM promoters with CRC risk were found and externally validated in studies by Hellebrekers et al. and Itzkowitz et al. [37, 39], respectively. The gene discussed is GATA4; the disease is colorectal carcinoma.